Shanghai Pharmaceuticals (SHA: 601607, HKG: 2607), a leading pharmaceutical company in China, has announced a long-term partnership with fellow Chinese medical device firm Mindray (SHE: 300760). The collaboration will focus on medical equipment, medical consumables, and in vitro diagnostic (IVD) products. The two companies plan to integrate their existing resources to promote joint programs, explore innovative marketing strategies, and expand the scope of their partnership. Financial details of the agreement were not disclosed.
Integrating Resources for Enhanced Collaboration
The partnership aims to leverage the strengths of both Shanghai Pharmaceutical and Mindray to enhance their offerings in the medical equipment and IVD sectors. By integrating their resources, the companies will be able to provide more comprehensive solutions and services to their customers.
Mindray’s Extensive Reach in China
Founded in 1991, Mindray has a significant presence across China, with units in over 30 provinces. The company’s products and services reach 110,000 medical institutions and cover 99% of Class 3 A hospitals in the country. This extensive network will be a valuable asset in the newly formed partnership.
Shanghai Pharmaceutical’s Pharmaceutical Supply Chain Expertise
Shanghai Pharmaceutical, on the other hand, is a national leader in pharmaceutical supply chain services, with a core focus on the distribution of drugs and medical devices. The company’s expertise in this area will complement Mindray’s offerings and contribute to the success of the partnership.-Fineline Info & Tech
